Search results for "E-F"

Some Decision Results on Nonrepetitive Words

1985

The paper addresses some generalizations of the Thue Problem such as: given a word u, does there exist an infinite nonrepetitive overlap free (or square free) word having u as a prefix? A solution to this as well as to related problems is given for the case of overlap free words on a binary alphabet.

The IEEE-FIPA Standard on the Design Process Documentation Template

2014

Nowadays, it is a matter of fact that a “one-size-fit-all” methodology or design process useful and fitting every kind of problem, situation, or design context does not exist. (Situational) Method Engineering (SME) discipline aims at determining techniques and tools for developing ad hoc design methodologies. SME mainly and highly focuses on the reuse of portion of existing design processes or methodologies (the method fragments). In order to have means for creating SME techniques and tools and for creating new design processes, some key elements are needed: a unique process metamodel for representing design processes and fragments, a proper template for the description of AO design process…

The OpenUp Process

2014

The Open Unified Process (OpenUp) is an iterative design process that structures the project lifecycle into four phases: Inception, Elaboration, Construction, and Transition. It is part of the Eclipse Process Framework and embraces a pragmatic, agile philosophy that focuses on the collaborative nature of software development. It is a tools-agnostic, low-ceremony process that can be extended to address a broad variety of project types. The project lifecycle provides stakeholders and team members with visibility and decision points throughout the project and makes them able to manage their work through micro-increments.

Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized s…

2002

Abstract Purpose: To compare a regimen of vinorelbine and cisplatin (VC) to the combination of mitomycin, vindesine, and cisplatin (MVP) in patients with stage IIIB or stage IV non-small cell lung cancer (NSCLC). The main endpoits were analysis of objective response rates, toxicity, time to progression, and overall survival. Patients and methods: 247 eligible patients were randomized to receive (a) vinorelbine 25 mg/m 2 intravenous bolus on days 1and 8 plus cisplatin 100 mg/m 2 on day 1 every 4 weeks, or (b) mitomycin c 8 mg/m 2 i.v. on day 1, vindesine 3 mg/m 2 i.v. on days 1, 8, 15 and 22, plus cisplatin 100 mg/m 2 on day 1 every 4 weeks. In subsequent cycles vindesine was given every oth…

Papillary muscle relocation and mitral annuloplasty in ischemic mitral valve regurgitation: midterm results.

2014

Objectives The surgical approach for ischemic mitral regurgitation remains unclear. Many studies are in favor of adding the subvalvular procedure to mitral annuloplasty to reduce recurrent mitral regurgitation. This study reports the clinical and echocardiographic outcomes of papillary muscle relocation combined with mitral annuloplasty.Methods From 2003, 115 patients with severe ischemic mitral regurgitation who underwent papillary muscle relocation plus nonrestrictive mitral annuloplasty and coronary artery bypass grafting were retrospective analyzed. Patients' mean age was 52 ± 12.8 years, New York Heart Association class III or IV was 71%, and preoperative left ventricular ejection frac…

New horizons in early stage COPD--improving knowledge, detection and treatment.

2011

SummaryEarly stage COPD carries a significant healthcare burden that is currently underrecognised, underdiagnosed and undertreated. Furthermore, patients at this stage can rapidly decline to advanced disease, especially if they continue to smoke. The natural history of the disease in early stages remains largely unknown, and emerging evidence indicates that we are able to reduce lung function decline and exacerbations, and improve quality of life, in early stage COPD, mainly through smoking cessation. But new evidence from randomised clinical trials also suggests an impact of pharmacotherapy on clinical outcomes in early disease. Guidelines need to be updated to reflect this greater underst…

A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or me…

2013

Abstract Background Pemetrexed plus cisplatin was approved for first-line treatment of non–small-cell lung cancer (NSCLC) in patients with nonsquamous histology after initiation of this study. This phase II study evaluated pemetrexed plus cisplatin and pemetrexed plus carboplatin as first-line treatments for stage IIIB/IV NSCLC. Patients and Methods The patients were randomized (1:1) to 2 parallel arms: pemetrexed (500 mg/m2) plus cisplatin (75 mg/m2) or pemetrexed (500 mg/m2) plus carboplatin (area under the curve 6) day 1 every 3 weeks (maximum, 6 cycles). Progression-free survival (PFS) was the primary objective; secondary objectives included overall survival (OS), 1-year survival, and s…

Degree-problems I squarefree character degrees

1985

The quantum trajectory approach to geometric phase for open systems

2005

The quantum jump method for the calculation of geometric phase is reviewed. This is an operational method to associate a geometric phase to the evolution of a quantum system subjected to decoherence in an open system. The method is general and can be applied to many different physical systems, within the Markovian approximation. As examples, two main source of decoherence are considered: dephasing and spontaneous decay. It is shown that the geometric phase is to very large extent insensitive to the former, i.e. it is independent of the number of jumps determined by the dephasing operator.

Light flavor and heavy quark spin symmetry in heavy meson molecules

2012

We propose an effective field theory incorporating light SU(3)-flavor and heavy quark spin symmetry to describe charmed meson-antimeson bound states. At lowest order the effective field theory entails a remarkable simplification: it only involves contact range interactions among the heavy meson and antimeson fields. We show that the isospin violating decays of the X(3872) can be used to constrain the interaction between the D and a (D) over bar* mesons in the isovector channel. As a consequence, we can rule out the existence of an isovector partner of the X(3872). If we additionally assume that the X(3915) and Y(4140) are D*(D) over bar* and D*(s)(D) over bar*(s) molecular states, we can de…